Pathologic and molecular features of screening low-dose computed tomography (LDCT)-detected lung cancer: A baseline and 2-year repeat study

Lung Cancer

Volumn 62, Issue 2, 2008, Pages 202-214

  Pelosi, Giuseppe ^a,b   Sonzogni, Angelica ^a   Veronesi, Giulia ^a   De Camilli, Elisa ^a   Maisonneuve, Patrick ^a   Spaggiari, Lorenzo ^a,b   Manzotti, Michela ^a   Masullo, Michele ^a   Taliento, Giulio ^a   Fumagalli, Caterina ^a   Bellomi, Massimo ^b   Travis, William D ^c   Kadivar, Maryam ^d   Viale, Giuseppe ^a,b  

^a EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^d IRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Baseline; Central scar; Invasion; K ras; Low dose computed tomography; Lung cancer; Mutation; Repeat; Screening

Indexed keywords

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER INVASION; CANCER SCREENING; CANCER SURGERY; DIAGNOSTIC IMAGING; EARLY DIAGNOSIS; FEMALE; GENE MUTATION; GENETIC SCREENING; HISTOLOGY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LOW DOSE COMPUTED TOMOGRAPHY; LUNG ADENOCARCINOMA; LUNG CARCINOMA; MAJOR CLINICAL STUDY; MALE; ONCOGENE K RAS; PREVALENCE; PRIORITY JOURNAL; SCAR; SEX DIFFERENCE; SMOKING HABIT; TUMOR VOLUME;

ADENOCARCINOMA; AGED; FEMALE; FOLLOW-UP STUDIES; GENES, RAS; HUMANS; LUNG NEOPLASMS; MALE; MASS SCREENING; MIDDLE AGED; MUTATION; PREVALENCE; TOMOGRAPHY, X-RAY COMPUTED;

EID: 52049088874     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lungcan.2008.03.012     Document Type: Article

References (62)

1. In: Travis W., Brambilla E., Muller-Hermelink H., and Harris C. (Eds). Tumours of the lung, pleura, thymus and heart (2004), IARC Press, Lyon
2. Spiro S., and Silvestri G. One hundred years of lung cancer. Am J Respir Crit Care Med 172 (2005) 523-529
3. Henschke C., McCauley D., Yankelevitz D., Naidich D., McGuinness G., Miettinen O., et al. Early Lung Cancer Action Project: overall design and findings from baseline screening. Lancet 354 (1999) 99-105
4. Henschke C., Naidich D., Yankelevitz D., McGuinness G., McCauley D., Smith J., et al. Early lung cancer action project: initial findings on repeat screenings. Cancer 92 (2001) 153-159
5. Henschke C., Yankelevitz D., Libby D., Pasmantier M., Smith J., and Miettinen O. Survival of patients with stage I lung cancer detected on CT screening. N Engl J Med 355 (2006) 1763-1771
6. Sone S., Nakayama T., Honda T., Tsushima K., Li F., Haniuda M., et al. CT findings of early-stage small cell lung cancer in a low-dose CT screening programme. Lung Cancer 56 (2007) 207-215
7. Callol L., Roig F., Cuevas A., de Granda J., Villegas F., Jareno J., et al. Low-dose CT: a useful and accessible tool for the early diagnosis of lung cancer in selected populations. Lung Cancer 56 (2007) 217-221
8. Molina J., and Adjei A. The Ras/Raf/MAPK pathway. J Thorac Oncol 1 (2006) 7-9
9. Fukuyama Y., Mitsudomi T., Sugio K., Ishida T., Akazawa K., and Sugimachi K. K-ras and p53 mutations are an independent unfavourable prognostic indicator in patients with non-small-cell lung cancer. Br J Cancer 75 (1997) 1125-1130
10. Rodenhuis S., Slebos R., Boot A., Evers S., Mooi W., Wagenaar S., et al. Incidence and possible clinical significance of K-ras oncogene activation in adenocarcinoma of the human lung. Cancer Res 48 (1988) 5738-5741
11. Slebos R., Kibbelaar R., Dalesio O., Kooistra A., Stam J., Meijer C., et al. K-ras oncogene activation as a prognostic marker in adenocarcinoma of the lung. N Engl J Med 323 (1990) 561-565
12. Cooper C., Carby F., Bubb V., Lamb D., Kerr K., and Wyllie A. The pattern of K-ras mutation in pulmonary adenocarcinoma defines a new pathway of tumour development in the human lung. J Pathol 181 (1997) 401-404
13. Ohshima S., Shimizu Y., and Takahama M. Detection of c-Ki-ras gene mutation in paraffin sections of adenocarcinoma and atypical bronchioloalveolar cell hyperplasia of human lung. Virchows Arch 424 (1994) 129-134
14. Sagawa M., Saito Y., Fujimura S., and Linnoila R. K-ras point mutation occurs in the early stage of carcinogenesis in lung cancer. Br J Cancer 77 (1998) 720-723
15. Westra W., Baas I., Hruban R., Askin F., Wilson K., Offerhaus G., et al. K-ras oncogene activation in atypical alveolar hyperplasias of the human lung. Cancer Res 56 (1996) 2224-2228
16. Wistuba I., and Gazdar A. Lung cancer preneoplasia. Annu Rev Pathol Mech Dis 1 (2006) 331-348
17. Wistuba I. Genetics of preneoplasia: lessons from lung cancer. Curr Mol Med 7 (2007) 3-14
18. Pajares M., Zudaire I., Lozano M., Agorreta J., Bastarrika G., Torre W., et al. Molecular profiling of computed tomography screen-detected lung nodules shows multiple malignant features. Cancer Epidemiol Biomarkers Prev 15 (2006) 373-380
19. Humphrey L., Teutsch S., and Johnson M. Lung cancer screening with sputum cytologic examination, chest radiography, and computed tomography: an update for the U.S. Preventive Services Task Force. Ann Intern Med 140 (2004) 740-753
20. Vazquez M.F., and Flieder D.B. Small peripheral glandular lesions detected by screening CT for lung cancer. A diagnostic dilemma for the pathologist. Radiol Clin North Am 38 (2000) 579-589
21. Flieder D., Vazquez M., Carter D., Brambilla E., Gazdar A., Noguchi M., et al. Pathologic findings of lung tumors diagnosed on baseline CT screening. Am J Surg Pathol 30 (2006) 606-613
22. Carter D., Vazquez M., Flieder D., Brambilla E., Gazdar A., Noguchi M., et al. Comparison of pathologic findings of baseline and annual repeat cancers diagnosed on CT screening. Lung Cancer 56 (2007) 193-199
23. Travis W., Garg K., Franklin W., Wistuba I., Sabloff B., Noguchi M., et al. Evolving concepts in the pathology and computed tomography imaging of lung adenocarcinoma and bronchioloalveolar carcinoma. J Clin Oncol 23 (2005) 3279-3287
24. Veronesi G, Bellomi M, Mulshine J, Pelosi G, Scanagatta P, Paganelli G, et al. Lung cancer screening with low-dose computed tomography: a non invasive diagnostic protocol for baseline lung nodules. Lung Cancer 2008 Feb 26 [Epub ahead of print].
25. Travis W., Garg K., Franklin W., Wistuba I., Sabloff B., Noguchi M., et al. Bronchioloalveolar carcinoma and lung adenocarcinoma: the clinical importance and research relevance of the 2004 World Health Organization pathologic criteria. J Thorac Oncol 1 (2006) S13-S19
26. Noguchi M., Morikawa A., Kawasaki M., Matsuno Y., Yamada T., Hirohashi S., et al. Small adenocarcinoma of the lung. Histologic characteristics and prognosis. Cancer 75 (1995) 2844-2852
27. Sakao Y., Miyamoto H., Sakuraba M., Oh T., Shiomi K., Sonobe S., et al. Prognostic significance of a histologic subtype in small adenocarcinoma of the lung: the impact of nonbronchioloalveolar carcinoma components. Ann Thorac Surg 83 (2007) 209-214
28. Terasaki H., Niki T., Matsuno Y., Yamada T., Maeshima A., Asamura H., et al. Lung adenocarcinoma with mixed bronchioloalveolar and invasive components: clinicopathological features, subclassification by extent of invasive foci, and immunohistochemical characterization. Am J Surg Pathol 27 (2003) 937-951
29. Shimizu K., Yoshida J., Nagai K., Nishimura M., Yokose T., Ishii G., et al. Visceral pleural invasion classification in non-small cell lung cancer: a proposal on the basis of outcome assessment. J Thorac Cardiovasc Surg 127 (2004) 1574-1578
30. Marchevsky A. Problems in pathologic staging of lung cancer. Arch Pathol Lab Med 130 (2006) 292-302
31. Nakata M., Sawada S., Yamashita M., Saeki H., Kurita A., Takashima S., et al. Surgical treatments for multiple primary adenocarcinoma of the lung. Ann Thorac Surg 78 (2004) 1194-1199
32. Martini N., and Melamed M. Multiple primary lung cancers. J Thorac Cardiovasc Surg 70 (1975) 606-612
33. Battafarano R., Meyers B., Guthrie T., Cooper J., and Patterson G. Surgical resection of multifocal non-small cell lung cancer is associated with prolonged survival. Ann Thorac Surg 74 (2002) 988-993
34. Terzi A., Falezza G., Benato C., Genestreti G., Santo A., Furia S., et al. Survival following complete resection of multifocal T4 node-negative NSCLC: a retrospective study. Thorac Cardiovasc Surg 55 (2007) 44-47
35. Ketchedjian A., Daly B., Fernando H., Florin L., Hunter C., Morelli D., et al. Location as an important predictor of lymph node involvement for pulmonary adenocarcinoma. J Thorac Cardiovasc Surg 132 (2006) 544-548
36. Micke P., Faldum A., Metz T., Beeh K., Bittinger F., Hengstler J., et al. Staging small cell lung cancer: Veterans Administration Lung Study Group versus International Association for the Study of Lung Cancer-what limits limited disease?. Lung Cancer 37 (2002) 271-276
37. Pelosi G., Scarpa A., Manzotti M., Veronesi G., Spaggiari L., Fraggetta F., et al. K-ras gene mutational analysis supports a monoclonal origin of biphasic pleomorphic carcinoma of the lung. Mod Pathol 17 (2004) 538-546
38. Pastorino U., Bellomi M., Landoni C., De Fiori E., Arnaldi P., Picchio M., et al. Early lung-cancer detection with spiral CT and positron emission tomography in heavy smokers: 2-year results. Lancet 362 (2003) 593-597
39. Nawa T., Nakagawa T., Kusano S., Kawasaki Y., Sugawara Y., and Nakata H. Lung cancer screening using low-dose spiral CT: results of baseline and 1-year follow-up studies. Chest 122 (2002) 15-20
40. Bastarrika G., Garcia-Velloso M., Lozano M., Montes U., Torre W., Spiteri N., et al. Early lung cancer detection using spiral computed tomography and positron emission tomography. Am J Respir Crit Care Med 171 (2005) 1378-1383
41. Swensen S., Jett J., Hartman T., Midthun D., Mandrekar S., Hillman S., et al. CT screening for lung cancer: five-year prospective experience. Radiology 235 (2005) 259-265
42. Swensen S., Jett J., Sloan J., Midthun D., Hartman T., Sykes A., et al. Screening for lung cancer with low-dose spiral computed tomography. Am J Respir Crit Care Med 165 (2002) 508-513
43. Swensen S., Jett J., Hartman T., Midthun D., Sloan J., Sykes A., et al. Lung cancer screening with CT: Mayo Clinic experience. Radiology 226 (2003) 756-761
44. Lindell R., Hartman T., Swensen S., Jett J., Midthun D., Tazelaar H., et al. Five-year lung cancer screening experience: CT appearance, growth rate, location, and histologic features of 61 lung cancers. Radiology 242 (2007) 555-562
45. Gohagan J., Marcus P., Fagerstrom R., Pinsky P., Kramer B., Prorok P., et al. Final results of the Lung Screening Study, a randomized feasibility study of spiral CT versus chest X-ray screening for lung cancer. Lung Cancer 47 (2005) 9-15
46. Bach P., Jett J., Pastorino U., Tockman M., Swensen S., and Begg C. Computed tomography screening and lung cancer outcomes. JAMA 297 (2007) 953-961
47. Gohagan J., Marcus P., Fagerstrom R., Pinsky P., Kramer B., and Prorok P. Baseline findings of a randomized feasibility trial of lung cancer screening with spiral CT scan vs chest radiograph: the Lung Screening Study of the National Cancer Institute. Chest 126 (2004) 114-121
48. Marcus P., Bergstralh E., Zweig M., Harris A., Offord K., and Fontana R. Extended lung cancer incidence follow-up in the Mayo Lung Project and overdiagnosis. J Natl Cancer Inst 98 (2006) 748-756
49. Marcus P., and Prorok P. Reanalysis of the Mayo Lung Project data: the impact of confounding and effect modification. J Med Screen 6 (1999) 47-49
50. Marcus P., Bergstralh E., Fagerstrom R., Williams D., Fontana R., Taylor W., et al. Lung cancer mortality in the Mayo Lung Project: impact of extended follow-up. J Natl Cancer Inst 92 (2000) 1308-1316
51. Marcus P. Lung cancer screening: an update. J Clin Oncol 19 (2001) 83S-86S
52. Oken M., Marcus P., Hu P., Beck T., Hocking W., Kvale P., et al. Baseline chest radiograph for lung cancer detection in the randomized prostate, lung, colorectal and ovarian cancer screening trial. J Natl Cancer Inst 97 (2005) 1832-1839
53. Pelosi G., Fraggetta F., Pasini F., Maisonneuve P., Sonzogni A., Iannucci A., et al. Immunoreactivity for thyroid transcription factor-1 in stage I non-small cell carcinomas of the lung. Am J Surg Pathol 25 (2001) 363-372
54. Buccheri G., and Ferrigno D. Lung cancer in North-West Italy: demographic and clinical trends in a hospital-based population of 1277 patients. Eur J Cancer Prev 12 (2003) 455-461
55. Suzuki K., Yokose T., Yoshida J., Nishimura M., Takahashi K., Nagai K., et al. Prognostic significance of the size of central fibrosis in peripheral adenocarcinoma of the lung. Ann Thorac Surg 69 (2000) 893-897
56. Hunt J., Strimas A., Martin J., Eyer M., Haddican M., Luckett B., et al. Differences in KRAS mutation spectrum in lung cancer cases between African Americans and Caucasians after occupational or environmental exposure to known carcinogens. Cancer Epidemiol Biomarkers Prev 11 (2002) 1405-1412
57. Siegfried J., Gillespie A., Mera R., Casey T., Keohavong P., Testa J., et al. Prognostic value of specific KRAS mutations in lung adenocarcinomas. Cancer Epidemiol Biomarkers Prev 6 (1997) 841-847
58. Chang Y., Wu C., Lin S., Hsiao C., Jou Y., and Lee Y. Clonality and prognostic implications of p53 and epidermal growth factor receptor somatic aberrations in multiple primary lung cancers. Clin Cancer Res 13 (2007) 52-58
59. Bianchi F., Hu J., Pelosi G., Cirincione R., Ferguson M., Ratcliffe K., et al. Lung cancers detected by screening with spiral computed tomography have a malignant phenotype when analyzed by cDNA microarray. Clin Cancer Res 10 (2004) 6023-6028
60. Porta M., Fernandez E., and Alguacil J. Semiology, proteomics, and the early detection of symptomatic cancer. J Clin Epidemiol 56 (2003) 815-819
61. Huang J., Behrens C., Wistuba I., Gazdar A., and Jagirdar J. Molecular analysis of synchronous and metachronous tumors of the lung: impact on management and prognosis. Ann Diagn Pathol 5 (2001) 321-329
62. Fernando H., Sasatomi E., Christie N., Buenaventura P., Finkelstein S., Yousem S., et al. Comparison of mutational changes in involved N1 lymph nodes with those in primary tumors in stage II non-small cell lung cancer: a pilot study. J Thorac Cardiovasc Surg 127 (2004) 87-91